A phase 3 trial of an oral fixed-dose combination of obicetrapib and ezetimibe showed a nearly 50% reduction in LDL cholesterol levels in patients at high risk for heart disease, without added safety concerns.
In October 2024, Tsuyoshi Kaneko, MD, WashU Medicine division director of cardiothoracic surgery at Barnes-Jewish Hospital, performed the hospital’s first robotic-assisted mitral valve surgery.
Researchers found that people respond differently to the same carbohydrate meals, with these variations linked to individual insulin resistance, beta-cell function, and microbiome profiles.
In a large study across 8 countries, researchers found that ultraprocessed food consumption contributed to thousands of premature deaths annually, with higher risks in countries where these foods dominate diets.
A new clinical trial is investigating whether removing clots using a modified access point can better prevent post-thrombotic syndrome in patients with extensive deep vein thrombosis.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
May’s FDA approvals include the first at-home HPV test, a blood-based Alzheimer’s diagnostic, biosimilars, AI-enabled imaging tools, and novel therapies across cardiology, pulmonology, neurology, gastroenterology, and more.
A large research review found that depression diagnosed in either midlife or late life was linked to a significantly higher risk of developing dementia.